{"id":606,"date":"2015-09-25T15:17:29","date_gmt":"2015-09-25T19:17:29","guid":{"rendered":"https:\/\/med.sites.unc.edu\/cfpulmcenter\/spirovation\/clinical-capabilities\/"},"modified":"2018-03-23T11:51:04","modified_gmt":"2018-03-23T15:51:04","slug":"clinical-capabilities","status":"publish","type":"page","link":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/","title":{"rendered":"Clinical Capabilities"},"content":{"rendered":"<p><!-- portlet_header --><\/p>\n<p><!-- portlet_above --><\/p>\n<p><!-- description --><\/p>\n<p class=\"lead\">We work with our partners to identify, design and execute joint research activities more efficiently and more strategically so that milestones are met as quickly and efficiently as possible.<\/p>\n<h2>Novel Airway Surface Pharmacokinetics Techniques<\/h2>\n<div class=\"O1\">These techniques include extensive experience in bronchoscopy of subjects post-drug delivery and direct (filter paper) and directed lavage techniques for making pharmacokinetic measurements of lung\/airway deposition. Also, e<span style=\"line-height: 1.43em\">xhaled breath condensate (EBC) can be analyzed with high sensitivity by mass spectroscopy offering the ability to measure the drug and metabolite concentration in airway surface liquid.<\/span><\/div>\n<h2>Measures of the Pulmonary Microbiome<\/h2>\n<div class=\"O1\">UNC has developed the capacity to measure the respiratory microbiome with 16S-454 pyrosequencing and Illumina MiSeq technologies. This technique has already been applied to studies of acute exacerbations in CF and COPD and measurement of antibiotic effects.<\/div>\n<div class=\"O1\">\n<h2>Novel Biomarkers for Pulmonary Drug Development<\/h2>\n<div class=\"O1\">Novel biomarkers for measuring the pharmacodynamic and therapeutic effects of inhaled therapeutic agents in sputum. <span style=\"line-height: 1.43em\">Measures of absolute mucin concentrations, mucin\/mucus osmotic pressure\/modulus, and measures of mucus adhesion in induced or spontaneously expectorated sputum. <\/span><span style=\"line-height: 1.43em\">The Sputum Core measures cell counts, cytokines, and growth factors in sputum and BAL.<\/span><\/div>\n<\/div>\n<div class=\"O1\"><\/div>\n<div class=\"O1\">\n<h2>Center for Environmental Medicine, Asthma &amp; Lung Biology<\/h2>\n<p>The CEMALB has great emphasis on translational studies of lung disease and biology.<\/p>\n<div class=\"O1\">\u2013Asthma<\/div>\n<div class=\"O1\">\u2013Allergy<\/div>\n<div class=\"O1\">\u2013COPD<\/div>\n<div class=\"O1\">\u2013Airway infection<\/div>\n<div class=\"O1\">\u2013Systemic effects of inhaled agents (primarily CV)<\/div>\n<div class=\"O1\">\n<p>Significant Clinical Research Infrastructure:<\/p>\n<div class=\"O1\">\u2022In vitro primary epithelial cell models<\/div>\n<div class=\"O1\">\u2022Clinical Research (study coordination, scintigraphy, exercise challenge, bronchoscopy)<\/div>\n<h3 class=\"O1\">Capabilities<\/h3>\n<div>\u2022Environmental Challenge<\/div>\n<div class=\"O1\" style=\"padding-left: 30px\">\u2013Ozone<\/div>\n<div class=\"O1\" style=\"padding-left: 30px\">\u2013PM (CAPS, Woodsmoke)<\/div>\n<div class=\"O1\" style=\"padding-left: 30px\">\u2013Other gases (NO2)<\/div>\n<div class=\"O1\" style=\"padding-left: 30px\">\u2013Allergen, Virus<\/div>\n<div class=\"O1\" style=\"padding-left: 30px\">\u2013IND for allergen and LPS challenge, approvals for ozone<\/div>\n<div class=\"O1\">\n<div>CEMALB and EPA investigators have developed phase I and IIa programs focused on potential interventions to mitigate the effect of pollutants on airway inflammation<\/div>\n<div>Studies of genetic and epigenetic regulators of pollutant response, and chemoprevention and pharmacologic intervention are established.<\/div>\n<\/div>\n<\/div>\n<h2>Environmental Challenge Studies and Exposure<\/h2>\n<p>The Center for Environmental Medicine has exposure chambers that allow for both short-term and long term human exposure studies.<\/p>\n<p>Approved challenge studies include:<\/p>\n<div class=\"O1\">\u2022House Dust Mite<\/div>\n<div class=\"O1\">\u2022Endotoxin<\/div>\n<div class=\"O1\">\u2022Allergen<\/div>\n<div class=\"O1\">\u2022Ozone<\/div>\n<div class=\"O1\">\u2022Exercise<\/div>\n<h2>CEMALB: Sputum Slide Reading, Biomarker and Biospecimen Core<\/h2>\n<p>The Core is a major resource for sample acquisition, processing, allocation, analysis, storage, tracking and security. The core serves as a central reading lab for sputum slides.<\/p>\n<h3 class=\"O1\">Biomarker Analysis in sputum\/BAL\/nasal lavage<\/h3>\n<div class=\"O1\">\u2022Total and Differential Leukocytes Counts<\/div>\n<div class=\"O1\">\u2022Cell viability<\/div>\n<div class=\"O1\">\u2022Proteomics on fluid phase components<\/div>\n<div class=\"O1\">\u2022Flow cytometric markers of cell function (phagocytosis, intracellular oxidative burst, cell surface marker expression)<\/div>\n<div class=\"O1\">\u2022Genomics: gene array; genotyping<\/div>\n<div class=\"O1\">\u2022% solids content<\/div>\n<div class=\"O1\">\u2022Cell isolation\/purification<\/div>\n<div class=\"O1\">\u2022Ex vivo stimulation assays<\/div>\n<div class=\"O1\">\u2022Single cell isolation and mRNA analysis using Isoraft technology<\/div>\n<div class=\"O1\"><\/div>\n<h3 class=\"O1\">Biospecimen\/Biorepository<\/h3>\n<div class=\"O1\">\n<div class=\"O1\">\u2022Banked human samples that include sputum supernatants, sputum cell pellets in Trizol, nasal lavage, EBC, serum, blood cell pellets in Trizol<\/div>\n<div class=\"O1\">\u2022Biorepository samples from the following subject cohorts at baseline, pre and post inhalation challenge (LPS, Ozone, virus, allergen, methacholine, hypertonic saline)<\/div>\n<div class=\"O2\">\u2022Healthy controls \u2013 Asthmatics \u2013 Allergics\/atopics \u2013 Smokers \u2013 COPD \u2013 CF \u2013 eCig users, Hookah users<\/div>\n<div class=\"O2\"><\/div>\n<h3 class=\"O2\">Phenotype Database<\/h3>\n<div class=\"O2\">\n<div class=\"O2\">\u2022Sputum endpoints on healthy and diseased subjects<\/div>\n<div class=\"O2\">\u2022Sputum producing capability (producers vs non-producers)<\/div>\n<div class=\"O2\">\u2022Responder vs non-responder status to inhalation challenges (ozone, lps)<\/div>\n<div class=\"O2\">\u2022Genotype status for target polymorphisms (GSTM1null)<\/div>\n<\/div>\n<\/div>\n<h2>Mucociliary Clearance &amp; Aerosol Research<\/h2>\n<p>The mission of the Mucociliary Clearance and Aerosol Research Laboratory is to use inhaled aerosols a<span style=\"line-height: 1.43em\">s a tool for studying lung physiology and; t<\/span><span style=\"line-height: 1.43em\">o improve treatment of pulmonary diseases such as cystic fibrosis, asthma, and chronic obstructive lung disease. <\/span><\/p>\n<h3>Areas of Focus<\/h3>\n<div>\n<p>Our extensive knowledge and experience in the use of radiolabeled aerosols and gamma scintigraphy allows us to assess clearance of mucus from the airways and the delivery of aerosols to the lung. We provide state-of-the-art clinical, animal, and bench research services for evaluating:<\/p>\n<div>\u2022The effectiveness of new therapies for improving clearance of secretions from the lung and;<\/div>\n<div>\u2022The efficiency of drug delivery to the lungs for new aerosol treatment devices.<\/div>\n<\/div>\n<h2>Pulmonary and Critical Care Clinical Research Facility<\/h2>\n<p>The Division of Pulmonary Medicine at UNC cares for patients with a wide range of pulmonary diseases, specializing in the care of lung cancer, sleep disorders, cystic fibrosis, pulmonary hypertension, non-CF bronchiolitis, lung transplant, a1-antitrypsin deficiency, sarcoidosis, pleural diseases and primary ciliary dyskinesia.<\/p>\n<h3>Facilities<\/h3>\n<div class=\"O1\">\u2022~4000 square feet of laboratory space, 4 patient exam rooms and waiting room space dedicated to clinical research<\/div>\n<div class=\"O1\">\u2022Mucociliary Clearance Imaging Lab<\/div>\n<div class=\"O1\">\u2022Specimen Processing\/storage facility<\/div>\n<div class=\"O1\">\u2022Fully equipped Pulmonary Function Labs for spirometry (including multiple portable KoKo spirometers), lung volumes, diffusion capacity, multiple breath washouts, nasal potential difference, sputum induction, ECG and vital signs<\/div>\n<div class=\"O1\">\u2022Phlebotomy lab<\/div>\n<h2>UNC Biomedical Research Imaging Center<\/h2>\n<p>The BRIC contains world-class imaging equipment, including a hybrid MRI\/PET whole body scanner, a 7 Tesla MRI whole body scanner, and a cyclotron \u2013 and is one of only two academic medical institutions in the United States that houses all three pieces of technology at one site.<\/p>\n<h3>Capabilities<\/h3>\n<div>\u2022Radiochemistry: Contains all equipment needed to support radiopharmaceutical development and production for molecular imaging studies under GMP.<\/div>\n<div class=\"O2\">\u2022PET probes include [18F]FDG, [11C]FMAU, [18F]FMAU, [18F]FHBG, [18F]5-fluorouracil, [15O]H2O, [15O]CO, [15O]CO2, [13N]NH3, and [18F-FB\/64Cu-DOTA]-RGD et al.<\/div>\n<div>\u2022Cyclotron:<\/div>\n<div class=\"O1\">\u2022GE PETtrace 880 Cyclotron is capable of accelerating both protons and deuterons for maximum flexibility.<\/div>\n<div class=\"O1\">\u2022ABT Biomarker Generator is dedicated to the production of 18F-FDG for clinical studies<\/div>\n<div>\u2022Small Animal Imaging includes: 9.4T MRI, Optical Systems, PET\/CT, SPECT, Ultrasound and CT Systems.<\/div>\n<div>\u2022Human Imaging: 3T MRI, PET\/MR, PET\/CT or 7T MRI equipment is available.<\/div>\n<div class=\"O1\">\u2022Hyperpolarized 19 F Lung Imaging<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>We work with our partners to identify, design and execute joint research activities more efficiently and more strategically so that milestones are met as quickly and efficiently as possible. Novel Airway Surface Pharmacokinetics Techniques These techniques include extensive experience in bronchoscopy of subjects post-drug delivery and direct (filter paper) and directed lavage techniques for making &hellip; <a href=\"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/\" aria-label=\"Read more about Clinical Capabilities\">Read more<\/a><\/p>\n","protected":false},"author":57194,"featured_media":0,"parent":140,"menu_order":16,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-606","page","type-page","status-publish","hentry","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clinical Capabilities | Marsico Lung Institute<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Capabilities | Marsico Lung Institute\" \/>\n<meta property=\"og:description\" content=\"We work with our partners to identify, design and execute joint research activities more efficiently and more strategically so that milestones are met as quickly and efficiently as possible. Novel Airway Surface Pharmacokinetics Techniques These techniques include extensive experience in bronchoscopy of subjects post-drug delivery and direct (filter paper) and directed lavage techniques for making &hellip; Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/\" \/>\n<meta property=\"og:site_name\" content=\"Marsico Lung Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2018-03-23T15:51:04+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/\",\"url\":\"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/\",\"name\":\"Clinical Capabilities | Marsico Lung Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/marsicolunginstitute\/#website\"},\"datePublished\":\"2015-09-25T19:17:29+00:00\",\"dateModified\":\"2018-03-23T15:51:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/marsicolunginstitute\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spirovation\",\"item\":\"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Clinical Capabilities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/marsicolunginstitute\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/marsicolunginstitute\/\",\"name\":\"Marsico Lung Institute\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/marsicolunginstitute\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Capabilities | Marsico Lung Institute","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/","og_locale":"en_US","og_type":"article","og_title":"Clinical Capabilities | Marsico Lung Institute","og_description":"We work with our partners to identify, design and execute joint research activities more efficiently and more strategically so that milestones are met as quickly and efficiently as possible. Novel Airway Surface Pharmacokinetics Techniques These techniques include extensive experience in bronchoscopy of subjects post-drug delivery and direct (filter paper) and directed lavage techniques for making &hellip; Read more","og_url":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/","og_site_name":"Marsico Lung Institute","article_modified_time":"2018-03-23T15:51:04+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/","url":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/","name":"Clinical Capabilities | Marsico Lung Institute","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/#website"},"datePublished":"2015-09-25T19:17:29+00:00","dateModified":"2018-03-23T15:51:04+00:00","breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/clinical-capabilities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/"},{"@type":"ListItem","position":2,"name":"Spirovation","item":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/spirovation\/"},{"@type":"ListItem","position":3,"name":"Clinical Capabilities"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/#website","url":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/","name":"Marsico Lung Institute","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/wp-json\/wp\/v2\/pages\/606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/wp-json\/wp\/v2\/users\/57194"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/wp-json\/wp\/v2\/comments?post=606"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/wp-json\/wp\/v2\/pages\/606\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/wp-json\/wp\/v2\/pages\/140"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/marsicolunginstitute\/wp-json\/wp\/v2\/media?parent=606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}